{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:30:03Z","timestamp":1786649403857,"version":"build-2736575974"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>More than half of Indian rural women (pregnant and non-pregnant) are anemic. Limited evidence exists on the effectiveness and tolerability of ferric carboxymaltose (FCM) in Indian rural and tribal women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims and Objectives:<\/jats:title>\n                    <jats:p>The primary objective was to assess the effectiveness of intravenous (IV) infusion of FCM in iron deficiency anemia (IDA) in rural and tribal women. Secondary objectives included evaluating changes in hematological parameters from baseline and assessing tolerability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>A prospective, open-label, observational, real-world, single-center study was conducted at Getwell Multispecialty Hospital, Manchar, Pune. Female patients with IDA (Pregnant: Hb 6 to &lt;11 g\/dL, non-pregnant: Hb: 6 to &lt;12 g\/dl) were recruited. FCM was administered as an IV infusion, and patients were followed up at 6 weeks. Change in Hb, other haematological parameters from baseline were assessed. Adverse effects related to FCM were monitored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Fifty-five patients completed the study; 7.27% were pregnant and 92.73% were nonpregnant. A significant increase in Hb of 3.64 g\/dL was recorded at 6 weeks. All pregnant women achieved the target Hb of 11 g\/dL, whereas 58.82% of nonpregnant women reached 12 g\/dL; there was a significant increase in hematocrit, mean corpuscular volume, mean corpuscular hemoglobin (MCH), and MCH concentration (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05 for all) as compared to baseline. FCM infusion was well tolerated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>FCM IV infusion significantly increased Hb levels and other hematological parameters at 6 weeks. FCM appears to be an effective and well-tolerated treatment for IDA in pregnant and non-pregnant women in rural and tribal area.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijabmr.ijabmr_193_25","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T19:00:25Z","timestamp":1766170825000},"page":"271-276","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Prospective Study in Rural and Tribal India"],"prefix":"10.4103","volume":"15","author":[{"given":"Mohan","family":"Sali","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Getwell Multispecialty Hospital, Pune, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepti","family":"Sali","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Getwell Multispecialty Hospital, Pune, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Varpe","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Getwell Multispecialty Hospital, Pune, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketan","family":"Kulkarni","sequence":"additional","affiliation":[{"name":"Department of Medical Services, Emcure Pharmaceuticals Limited, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shridevi","family":"Gundu","sequence":"additional","affiliation":[{"name":"Department of Medical Services, Emcure Pharmaceuticals Limited, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Suryawanshi","sequence":"additional","affiliation":[{"name":"Department of Medical Services, Emcure Pharmaceuticals Limited, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"R1-20260420","doi-asserted-by":"crossref","first-page":"e000759","DOI":"10.1136\/bmjgast-2021-000759","article-title":"Iron deficiency anaemia: Pathophysiology, assessment, practical management","volume":"9","author":"Kumar","year":"2022","journal-title":"BMJ Open Gastroenterol"},{"key":"R2-20260420","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s13045-021-01202-2","article-title":"Burden of anemia and its underlying causes in 204 countries and territories, 1990\u20132019: Results from the Global Burden of Disease Study 2019","volume":"14","author":"Safiri","year":"2021","journal-title":"J Hematol Oncol"},{"key":"R4-20260420","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12884-019-2200-3","article-title":"Comparison of ferric Carboxymaltose and iron sucrose complex for treatment of iron deficiency anemia in pregnancy- randomised controlled trial","volume":"19","author":"Jose","year":"2019","journal-title":"BMC Pregnancy Childbirth"},{"key":"R5-20260420","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.bjhh.2015.08.012","article-title":"Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia","volume":"37","author":"Friedrisch","year":"2015","journal-title":"Rev Bras Hematol Hemoter"},{"key":"R6-20260420","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4103\/2229-516X.149230","article-title":"Ferric carboxymaltose: A revolution in the treatment of postpartum anemia in Indian women","volume":"5","author":"Rathod","year":"2015","journal-title":"Int J Appl Basic Med Res"},{"key":"R7-20260420","first-page":"184","article-title":"The differences and similarities between two-sample T-test and paired T-test","volume":"29","author":"Xu","year":"2017","journal-title":"Shanghai Arch Psychiatry"},{"key":"R8-20260420","doi-asserted-by":"crossref","first-page":"e171058","DOI":"10.1172\/JCI171058","article-title":"Guidelines for repeated measures statistical analysis approaches with basic science research considerations","volume":"133","author":"Muhammad","year":"2023","journal-title":"J Clin Invest"},{"key":"R10-20260420","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00404-018-4782-9","article-title":"Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy","volume":"298","author":"Froessler","year":"2018","journal-title":"Arch Gynecol Obstet"},{"key":"R11-20260420","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12905-017-0506-8","article-title":"Effectiveness and safety of ferric carboxymaltose compared to iron sucrose in women with iron deficiency anemia: Phase IV clinical trials","volume":"18","author":"Naqash","year":"2018","journal-title":"BMC Womens Health"},{"key":"R12-20260420","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2147\/JBM.S361210","article-title":"Efficacy and safety of ferric carboxymaltose in the management of iron deficiency anemia: A multi-center real-world study from India","volume":"13","author":"Charmila","year":"2022","journal-title":"J Blood Med"},{"key":"R13-20260420","first-page":"1","article-title":"Effect of IV ferric carboxy maltose for moderate\/severe anemia: A systematic review and meta-analysis","volume":"11","author":"Khatib","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"R14-20260420","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s13224-022-01653-8","article-title":"A randomised controlled trial to compare injection ferric carboxymaltose and oral iron in treating iron deficiency anemia during pregnancy","volume":"72","author":"Chawla","year":"2022","journal-title":"J Obstet Gynaecol India"},{"key":"R15-20260420","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/ejhf.2478","article-title":"Health status improvement with ferric carboxymaltose in heart failure with reduced ejection fraction and iron deficiency","volume":"24","author":"Butler","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"R16-20260420","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.3390\/jcm11102786","article-title":"Ferric carboxymaltose improves the quality of life of patients with inflammatory bowel disease and iron deficiency without anaemia","volume":"11","author":"Huguet","year":"2022","journal-title":"J Clin Med"},{"key":"R17-20260420","doi-asserted-by":"crossref","first-page":"991.e1","DOI":"10.1016\/j.amjmed.2017.03.045","article-title":"Iron supplementation, response in iron-deficiency anemia: Analysis of five trials","volume":"130","author":"Okam","year":"2017","journal-title":"Am J Med"}],"container-title":["International Journal of Applied &amp; Basic Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijabmr.ijabmr_193_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:53:42Z","timestamp":1786647222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijabmr.ijabmr_193_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/ijabmr.ijabmr_193_25","relation":{},"ISSN":["2229-516X","2248-9606"],"issn-type":[{"value":"2229-516X","type":"print"},{"value":"2248-9606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"2025-04-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}